The Potential Role of Necroptosis in Clinical Diseases (Review)

Wenli Dai,Jin Cheng,Xi Leng,Xiaoqing Hu,Yingfang Ao
DOI: https://doi.org/10.3892/ijmm.2021.4922
IF: 5.314
2021-01-01
International Journal of Molecular Medicine
Abstract:As an important type of programmed cell death in addition to apoptosis, necroptosis occurs in a variety of pathophysiological processes, including infections, liver diseases, kidney injury, neurodegenerative diseases, cardiovascular diseases, and human tumors. It can be triggered by a variety of factors, such as tumor necrosis factor receptor and Toll‑like receptor families, intracellular DNA and RNA sensors, and interferon, and is mainly mediated by receptor‑interacting protein kinase 1 (RIP1), RIP3, and mixed lineage kinase domain‑like protein. A better understanding of the mechanism of necroptosis may be useful in the development of novel drugs for necroptosis‑related diseases. In this review, the focus is on the molecular mechanisms of necroptosis, exploring the role of necroptosis in different pathologies, discussing their potential as a novel therapeutic target for disease therapy, and providing suggestions for further study in this area.
What problem does this paper attempt to address?